Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Provention Bio
Provention Bio
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Endpoints
Wed, 10/23/19 - 10:12 am
Provention Bio
JNJ
Crohn's Disease
clinical trials
PRV-6527
A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight
Fierce Biotech
Sat, 01/5/19 - 12:09 am
type 1 diabetes
Provention Bio
vaccines
PRV-101
Eight years after Eli Lilly dumped it, an upstart biotech has nabbed teplizumab and filed a $56M IPO to back a PhIII comeback
Endpoints
Thu, 05/10/18 - 11:02 pm
teplizumab
Eli Lilly
Provention Bio
IPOs
diabetes
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Provention Bio wants to stop Type I diabetes – with a vaccine
Drug Delivery Business News
Tue, 07/25/17 - 10:17 am
Provention Bio
type 1 diabetes
vaccines
Pages
« first
‹ previous
1
2